The Global C3 Glomerulopathy Market Size was Worth around USD 2.19 Billion in 2024 and is predicted to Grow to around USD 4.44 Billion by 2035 with a Compound Annual Growth Rate (CAGR) of 6.64% from 2025 to 2035. The opportunities for C3 glomerulopathy market expansion are created by the rise in the number of perinatal infection treatments provided by retail pharmacies as well as the expansion of retail pharmacies in highly developed nations.